FDA Approves First Drug for Treatment of Chorea in Huntington’s Disease

kavin submitted, created time 3 months 4 days (www.fda.gov)

The U.S. Food and Drug Administration has approved Xenazine (tetrabenazine) for the treatment of chorea in people with Huntington’s disease. Chorea is the jerky, involuntary movement that occurs in people with this disease.

Xenazine is a new drug and is the first treatment of any kind approved in the United States for any symptom of Huntington’s disease. Currently there are no other drugs that are FDA-approved to treat chorea.

Serious side effects reported with use of Xenazine include depression and suicidal thoughts and actions

2 comments | Blog It | Email It | Keywords: orphan products mutations orphan drugs dopamine side effects suicide depression tetrabenazine Xenazine huntington's Huntington’s Disease FDA chorea